Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Heart failure patients can treat edema at home | ACC Medicare fee calculator | Nonobstructive HCM drug gets FDA priority
Monday, August 3, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

FDA clears autoinjector drug for home treatment of heart failure edema

A new drug delivery system may help reduce heart failure hospitalizations and related healthcare costs, which are expected to reach $70 billion by 2030.

READ MORE >
The U.S. FDA has approved furosemide injection (Furoscix ReadyFlow) for the treatment of fluid overload in adults with heart failure or chronic kidney disease.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears autoinjector drug for home treatment of heart failure edema

Share on Twitter Share on Facebook Share on Linkedin
The U.S. FDA has approved furosemide injection (Furoscix ReadyFlow) for the treatment of fluid overload in adults with heart failure or chronic kidney disease.
A new drug delivery system may help reduce heart failure hospitalizations and related healthcare costs, which are expected to reach $70 billion by 2030.
READ MORE >

ACC releases calculator for payments based on 2027 Medicare physician fee schedule

ACC created a Medicare payment calculator for practices to see the possible impacts on their 2027 payments.

READ MORE >
The Medicare Physician Fee Schedule again has reductions for payments physicians receive. Medicare Money
Share on Twitter Share on Facebook Share on Linkedin

ACC releases calculator for payments based on 2027 Medicare physician fee schedule

Share on Twitter Share on Facebook Share on Linkedin
The Medicare Physician Fee Schedule again has reductions for payments physicians receive. Medicare Money
ACC created a Medicare payment calculator for practices to see the possible impacts on their 2027 payments.
READ MORE >

Drug that treats nonobstructive HCM gains FDA Fast Track designation

The investigational drug down regulates WISPER, a heart stress-specific lncRNA that is overexpressed in hypertrophic cardiomyopathy cardiac fibrosis.

READ MORE >
There were numerous sessions and an AHA information booth on hypertrophic cardiomyopathy (HCM) at the American Heart Association 2022 meeting.
Share on Twitter Share on Facebook Share on Linkedin

Drug that treats nonobstructive HCM gains FDA Fast Track designation

Share on Twitter Share on Facebook Share on Linkedin
There were numerous sessions and an AHA information booth on hypertrophic cardiomyopathy (HCM) at the American Heart Association 2022 meeting.
The investigational drug down regulates WISPER, a heart stress-specific lncRNA that is overexpressed in hypertrophic cardiomyopathy cardiac fibrosis.
READ MORE >

Featured Articles

Medtronic leads $37M investment in CoreMap’s AFib mapping tech

The company's flagship technology was invented by Peter Spector, MD, a practicing electrophysiologist. It uses advanced electrodes to visualize details of AFib typically missed by other mapping systems.

READ MORE >
money capital dollar business loan funds
Share on Twitter Share on Facebook Share on Linkedin

Medtronic leads $37M investment in CoreMap’s AFib mapping tech

Share on Twitter Share on Facebook Share on Linkedin
money capital dollar business loan funds
The company's flagship technology was invented by Peter Spector, MD, a practicing electrophysiologist. It uses advanced electrodes to visualize details of AFib typically missed by other mapping systems.
READ MORE >

AHA heart failure registry making a major impact after 20 years

The registry has collected more than 1.6 million patient records from more than 800 hospitals. "We can do even better," one cardiologist said. "We have to treat heart failure with everything we've got."

READ MORE >
Video: Clyde W. Yancy, MD MSc, FHFSA, chief of cardiology and professor of medicine at Northwestern University, and Stephen Greene, MD, a heart failure cardiologist and professor of medicine at Duke University Medical Center, discuss the milestone of collecting 20 years of data from the American Heart Association (AHA) Get With the Guidelines for Heart Failure program.
Share on Twitter Share on Facebook Share on Linkedin

AHA heart failure registry making a major impact after 20 years

Share on Twitter Share on Facebook Share on Linkedin
Video: Clyde W. Yancy, MD MSc, FHFSA, chief of cardiology and professor of medicine at Northwestern University, and Stephen Greene, MD, a heart failure cardiologist and professor of medicine at Duke University Medical Center, discuss the milestone of collecting 20 years of data from the American Heart Association (AHA) Get With the Guidelines for Heart Failure program.
The registry has collected more than 1.6 million patient records from more than 800 hospitals. "We can do even better," one cardiologist said. "We have to treat heart failure with everything we've got."
READ MORE >

Safety a top priority as more heart procedures move to outpatient settings

The push to move certain procedures to ambulatory surgical centers is one of the biggest business trends in electrophysiology. Medical societies are watching this space closely to ensure high quality remains the goal.

READ MORE >
Video interview with Joseph E. Marine, MD, MBA, Vice-Director of Operations, Division of Cardiology, Section Chief of Cardiology, Johns Hopkins Community Physicians, and Professor of Medicine at Johns Hopkins University, explains the growing trend of using ambulatory surgical centers (ASCs) for cardiac and electrophysiology (EP) procedures.
Share on Twitter Share on Facebook Share on Linkedin

Safety a top priority as more heart procedures move to outpatient settings

Share on Twitter Share on Facebook Share on Linkedin
Video interview with Joseph E. Marine, MD, MBA, Vice-Director of Operations, Division of Cardiology, Section Chief of Cardiology, Johns Hopkins Community Physicians, and Professor of Medicine at Johns Hopkins University, explains the growing trend of using ambulatory surgical centers (ASCs) for cardiac and electrophysiology (EP) procedures.
The push to move certain procedures to ambulatory surgical centers is one of the biggest business trends in electrophysiology. Medical societies are watching this space closely to ensure high quality remains the goal.
READ MORE >

Cleerly and Allelica launch a new tool for assessing genetic risk in heart patients

The new test is designed to be used on its own or in tandem with Cleerly’s AI-powered CCTA evaluations. 

READ MORE >
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
Share on Twitter Share on Facebook Share on Linkedin

Cleerly and Allelica launch a new tool for assessing genetic risk in heart patients

Share on Twitter Share on Facebook Share on Linkedin
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
The new test is designed to be used on its own or in tandem with Cleerly’s AI-powered CCTA evaluations. 
READ MORE >

New PARTNER 3 update links TAVR to early benefits over SAVR

Low-risk patients face comparable outcomes after TAVR and SAVR, researchers wrote, making it important to highlight even the smallest differences between these two approaches. 

READ MORE >
elderly patient and doctor
Share on Twitter Share on Facebook Share on Linkedin

New PARTNER 3 update links TAVR to early benefits over SAVR

Share on Twitter Share on Facebook Share on Linkedin
elderly patient and doctor
Low-risk patients face comparable outcomes after TAVR and SAVR, researchers wrote, making it important to highlight even the smallest differences between these two approaches. 
READ MORE >

Man who killed family in murder-suicide was a former American Heart Association employee

Authorities believe a 47-year-old Michigan man killed his wife and six children before taking his own life. "This is an unspeakable tragedy that we may never completely understand,” one official said. 

READ MORE >
Gunman kills 4, including his former doctor, in Oklahoma hospital shooting.
Share on Twitter Share on Facebook Share on Linkedin

Man who killed family in murder-suicide was a former American Heart Association employee

Share on Twitter Share on Facebook Share on Linkedin
Gunman kills 4, including his former doctor, in Oklahoma hospital shooting.
Authorities believe a 47-year-old Michigan man killed his wife and six children before taking his own life. "This is an unspeakable tragedy that we may never completely understand,” one official said. 
READ MORE >

In Other News

CMS announces end to Medicare Part D prescription drug subsidies

With the change, premiums are expected to rise. However, the Centers for Medicare & Medicaid Services confirmed they cannot inflate by more than 6%, as capped by the Inflation Reduction Act. 

READ MORE >
healthcare costs drug prices
Share on Twitter Share on Facebook Share on Linkedin

CMS announces end to Medicare Part D prescription drug subsidies

Share on Twitter Share on Facebook Share on Linkedin
healthcare costs drug prices
With the change, premiums are expected to rise. However, the Centers for Medicare & Medicaid Services confirmed they cannot inflate by more than 6%, as capped by the Inflation Reduction Act. 
READ MORE >

5 reasons patients check with a chatbot before—and often instead of—going to the doctor

Warning healthcare consumers about the unreliability of AI for medical advice is like screaming at tourists for frolicking in a decorative fountain on an oppressively hot and humid day. 

READ MORE >
smartphone chatbot
Share on Twitter Share on Facebook Share on Linkedin

5 reasons patients check with a chatbot before—and often instead of—going to the doctor

Share on Twitter Share on Facebook Share on Linkedin
smartphone chatbot
Warning healthcare consumers about the unreliability of AI for medical advice is like screaming at tourists for frolicking in a decorative fountain on an oppressively hot and humid day. 
READ MORE >

Judge rejects lawsuit from 26 states challenging Medicaid work requirements

A U.S. District Court judge ruled that the states were unable to show they would be irreparably harmed by complying with the policy, as the Centers for Medicare & Medicaid Services is covering 90% of the associated costs.

READ MORE >
Medicaid protesters
Share on Twitter Share on Facebook Share on Linkedin

Judge rejects lawsuit from 26 states challenging Medicaid work requirements

Share on Twitter Share on Facebook Share on Linkedin
Medicaid protesters
A U.S. District Court judge ruled that the states were unable to show they would be irreparably harmed by complying with the policy, as the Centers for Medicare & Medicaid Services is covering 90% of the associated costs.
READ MORE >

ICU overhaul ahead? Here’s where to start

Hospital leaders contemplating a rebuild of the intensive care unit should gather intensivists, architects, engineers and—not last and not least—ICU nurses. A new peer-reviewed paper lays out a blueprint for project planning.  

READ MORE >
hospital room
Share on Twitter Share on Facebook Share on Linkedin

ICU overhaul ahead? Here’s where to start

Share on Twitter Share on Facebook Share on Linkedin
hospital room
Hospital leaders contemplating a rebuild of the intensive care unit should gather intensivists, architects, engineers and—not last and not least—ICU nurses. A new peer-reviewed paper lays out a blueprint for project planning.  
READ MORE >

CT radiation doses have decreased substantially over the last decade

Dose reductions over the last decade were greatest for chest exams with contrast (31%) and without (27%), experts detail in RSNA's Radiology. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

CT radiation doses have decreased substantially over the last decade

Share on Twitter Share on Facebook Share on Linkedin
Dose reductions over the last decade were greatest for chest exams with contrast (31%) and without (27%), experts detail in RSNA's Radiology. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup